U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07698210) titled 'A Study of LY4178256 in Healthy Participants' on July 08.
Brief Summary: The main purpose of this study is to evaluate how well LY4178256 is tolerated and what side effects may occur in healthy participants. Blood tests will be performed to check how much LY4178256 gets into the bloodstream and how long it takes the body to eliminate it. For each participant, the study will last about 7 months and will include either 7 or 12 visits depending on the assigned treatment.
Study Start Date: July, 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: LY4178256
Administered intravenously (IV)
DRUG: Place...